Naloxone Spray Market
Naloxone Spray Market - Global Industry Assessment & Forecast
Segments Covered
- By Dosage 2 mg/actuation, 4 mg/actuation, Others
- By Distribution Channel Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 380 Million |
Revenue 2030: | USD 1.4 Billion |
Revenue CAGR (2023 - 2030): | 19.90% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Naloxone Spray Market - Segment Analysis
- Overview
- Global Naloxone Spray Market, 2016 - 2028 (USD Million)
-
Global Naloxone Spray Market - by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
Global Naloxone Spray Market - by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
Global Naloxone Spray Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Naloxone Spray Market - Segment Analysis
- Overview
- North America Naloxone Spray Market, 2016 - 2028 (USD Million)
-
North America Naloxone Spray Market, by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
North America Naloxone Spray Market, by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
North America Naloxone Spray Market, by Country
- U.S.
- U.S. Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- U.S. Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- U.S. Naloxone Spray Market, By Dosage
- Canada
- Canada Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Canada Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Canada Naloxone Spray Market, By Dosage
- Mexico
- Mexico Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Mexico Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Mexico Naloxone Spray Market, By Dosage
- U.S.
-
Europe Naloxone Spray Market - Segment Analysis
- Overview
- Europe Naloxone Spray Market, 2016 - 2028 (USD Million)
-
Europe Naloxone Spray Market, by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
Europe Naloxone Spray Market, by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
Europe Naloxone Spray Market, by Country
- Germany
- Germany Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Germany Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Germany Naloxone Spray Market, By Dosage
- UK
- UK Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- UK Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- UK Market, By Dosage
- France
- France Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- France Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- France Naloxone Spray Market, By Dosage
- Spain
- Spain Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Spain Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Spain Naloxone Spray Market, By Dosage
- Italy
- Italy Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Italy Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Italy Naloxone Spray Market, By Dosage
- BENELUX
- BENELUX Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- BENELUX Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- BENELUX Naloxone Spray Market, By Dosage
- Rest of Europe
- Rest Of Europe Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Rest Of Europe Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Rest Of Europe Naloxone Spray Market, By Dosage
- Germany
-
Asia Pacific Naloxone Spray Market - Segment Analysis
- Overview
- Asia Pacific Naloxone Spray Market, 2016 - 2028 (USD Million)
-
Asia Pacific Naloxone Spray Market, by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
Asia Pacific Naloxone Spray Market, by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
Asia Pacific Naloxone Spray Market, by Country
- China
- China Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- China Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- China Naloxone Spray Market, By Dosage
- Japan
- Japan Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Japan Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Japan Naloxone Spray Market, By Dosage
- India
- India Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- India Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- India Naloxone Spray Market, By Dosage
- South Korea
- South Korea Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- South Korea Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- South Korea Naloxone Spray Market, By Dosage
- South East Asia
- South East Asia Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- South East Asia Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- South East Asia Naloxone Spray Market, By Dosage
- Rest of Asia Pacific
- Rest of Asia Pacific Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Rest of Asia Pacific Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Rest of Asia Pacific Naloxone Spray Market, By Dosage
- China
-
Latin America Naloxone Spray Market - Segment Analysis
- Overview
- Latin America Naloxone Spray Market, 2016 - 2028 (USD Million)
-
Latin America Naloxone Spray Market, by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
Latin America Naloxone Spray Market, by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
Latin America Naloxone Spray Market, by Country
- Brazil
- Brazil Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Brazil Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Brazil Naloxone Spray Market, By Dosage
- Argentina
- Argentina Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Argentina Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Argentina Naloxone Spray Market, By Dosage
- Rest of Latin America
- Rest of Latin America Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Rest of Latin America Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Rest of Latin America Naloxone Spray Market, By Dosage
- Brazil
-
Middle East & Africa Naloxone Spray Market - Segment Analysis
- Overview
- Middle East & Africa Naloxone Spray Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Naloxone Spray Market, by Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
-
Middle East & Africa Naloxone Spray Market, by Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
-
Middle East & Africa Naloxone Spray Market, by Country
- GCC Countries
- GCC Countries Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- GCC Countries Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- GCC Countries Naloxone Spray Market, By Dosage
- South Africa
- South Africa Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- South Africa Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- South Africa Naloxone Spray Market, By Dosage
- Rest of Middle East & Africa
- Rest of Middle East & Africa Naloxone Spray Market, By Dosage
- By 2 mg/actuation
- By 4 mg/actuation
- By Others
- Rest of Middle East & Africa Naloxone Spray Market, By Distribution Channel
- By Hospitals
- By Clinics
- By Retail Pharmacies
- By Online Pharmacies
- By Others
- Rest of Middle East & Africa Naloxone Spray Market, By Dosage
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Emergent BioSolutions (US)
- Pfizer (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Opiant Pharmaceuticals (US)
- Hikma Pharmaceuticals (UK)
- Nasus Pharma (Israel)
- Amphastar Pharmaceuticals (US)
- Indivior PLC (US)
- Samarth Pharma Pvt. Ltd. (India)
- Troikaa Pharmaceuticals Ltd. (India)
- and Neon Laboratories Limited (India).
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Naloxone Spray in terms of revenue?
-
The global Naloxone Spray valued at USD 380 Million in 2022 and is expected to reach USD 1.4 Billion in 2030 growing at a CAGR of 19.90%.
Which are the prominent players in the market?
-
The prominent players in the market are Emergent BioSolutions (US), Pfizer (US), Teva Pharmaceutical Industries Ltd. (Israel), Opiant Pharmaceuticals (US), Hikma Pharmaceuticals (UK), Nasus Pharma (Israel), Amphastar Pharmaceuticals (US), Indivior PLC (US), Samarth Pharma Pvt. Ltd. (India), Troikaa Pharmaceuticals Ltd. (India), and Neon Laboratories Limited (India)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 19.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Naloxone Spray include
- Launches and Approval of New Spray
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Naloxone Spray in 2022.